Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17424
Abstract: In a recent article by Chijiwa et al.1 , anti-IL-17A antibody (secukinumab; SEC) administration was reported to reduce the elevated levels of serum KL-6 in patients with psoriasis. We have encountered a unique case of psoriasis… read more here.
Keywords: psoriasis vulgaris; paradoxical exacerbation; secukinumab; psoriasis ... See more keywords